About Halozyme (HALO)
Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes and other drug candidates. The Company's segment... Read more
- USD38.46
- USD39.02
- USD38.46
- USD45.00
- -3.80%
- 829M
- 547.13k
- 865.40k
- 4.9B
- 29.85
- 17.40%
- 10.50%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
